Financhill
Back

Freeport-McMoRan Vs. Axsome Therapeutics Industry Stock Comparison

Sell
36

FCX
Freeport-McMoRan

Last Price:
$39.02
Seasonality Move:
-1.18%
Sell
32

AXSM
Axsome Therapeutics

Last Price:
$105.03
Seasonality Move:
-0.08%
Sell
36
Freeport-McMoRan (FCX) is a Sell

Is Freeport-McMoRan a Buy, Sell or Hold?

  • The current Freeport-McMoRan [FCX] share price is $37.70. The Score for FCX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • FCX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Axsome Therapeutics (AXSM) is a Sell

Is Axsome Therapeutics a Buy, Sell or Hold?

  • The current Axsome Therapeutics [AXSM] share price is $104.35. The Score for AXSM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • AXSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCX Stock Price Chart

What is Freeport-McMoRan's stock price today?

  • The Freeport-McMoRan share price today is $37.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing slight selling pressure.

AXSM Stock Price Chart

What is Axsome Therapeutics's stock price today?

  • The Axsome Therapeutics share price today is $104.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight selling pressure.

FCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.61 Buy
Relative Strength Index (14 RSI): 51.71 Buy
Chaikin Money Flow: -91711 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.46 - 38.88) Buy
Bollinger Bands (100): (34.96 - 39.92) Buy

AXSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.9 Sell
Relative Strength Index (14 RSI): 42.26 Sell
Chaikin Money Flow: -190981 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.56 - 111.3) Sell
Bollinger Bands (100): (95.54 - 123.4) Sell

FCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.49 Sell
20-day SMA: 37.82 Sell
50-day SMA: 36.92 Buy
200-day SMA: 40.98 Sell
8-day EMA: 38.17 Sell
20-day EMA: 37.64 Buy
50-day EMA: 37.23 Buy
200-day EMA: 40 Sell

AXSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 106.36 Sell
20-day SMA: 108.87 Sell
50-day SMA: 110.56 Sell
200-day SMA: 100.27 Buy
8-day EMA: 106.76 Sell
20-day EMA: 107.72 Sell
50-day EMA: 109.26 Sell
200-day EMA: 101.39 Buy

Freeport-McMoRan Earnings Growth & FCX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.13 per share, and an increase next year of $0.60 per share.

Axsome Therapeutics Earnings Growth & AXSM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.99 per share, an increase this year of $1.51 per share, and an increase next year of $4.87 per share.

Freeport-McMoRan Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Axsome Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):